Description

We are issuing this notice to help drug manufacturers and sponsors when preparing the Canadian-specific considerations and elements in the risk management plans (RMPs) for certain drug products. This notice describes what is required for certain drug products.

Resources

Name	Format	Description	Link
Notice of clarification to drug manufacturers and sponsors: Canadian-specific considerations in risk management plans	HTML		https://www.canada.ca/en/health-canada/services/drugs-health-products/reports-publications/medeffect-canada/profile-guidance-document-submission-risk-management-plans-follow-commitments/notice-clarification-drug-manufacturers-sponsors.html
Notice of clarification to drug manufacturers and sponsors: Canadian-specific considerations in risk management plans	HTML		https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/rapports-publications/medeffet-canada/profil-ligne-directrice-presentation-plans-gestion-risques-engagements-matiere-suivi/avis-clarification-fabricants-promoteurs-medicaments.html

Tags

Topics

Categories